Webmaking them available to all healthcare practitioners and institutions, and, thus PluroGen Therapeutics was conceived. Dr. Rodeheaver, Chairman of the Board of Directors, and Dr. Katz, Secretary, Treasurer and Board Member founded the Company at the end of 2005 and licensed the technology Dr. Rodeheaver invented from the UVA Patent Foundation. WebVice President Medical and Scientific Affairs, Plurogen Therapeutics, Charlotte, Virginia. Consultants In addition, we have an association of consultants having extensive experience in the clinical care of burns and wounds. Our Partners In order to provide premium service to our clients, we partner with Scintellix, LLC
Plurogen Therapeutics by Susan Chaplinsky, Dan Goodall, Cindy …
WebPluroGen Therapeutics, Inc. On track to be the 1st topical antibiotic for Diabetic Ulcers approved by FDA, PluroGen specializes in simple solutions for burns and wounds. Stage $500K in TTM Revenue. Industry Biotechnology. Location Norristown, PA, USA. WebPluroGel®• PSSD is targeted for routine use in patients with burns and chronic (non-healing) wounds. Clinical use of PluroGel®products in Europe has now reached over 14,000 non-healing wound patients with results that correlate to improved wound healing, pain reduction and cost reduction compared to standard of care products. down hill dozing
PluroGen Therapeutics - Darden Business Publishing …
WebTranslate Bio went public in June 2024 (NASDAQ: TBIO). “Translate Bio is the combination of two passionate teams of scientists coming together under one shared mission: to … WebApr 14, 2008 · PluroGen is a wound-healing company commercializing its patent-protected gel technology platform that provides superior and differentiated physical and bio-impact … Webaddress: 503 Broadleaf Way. Charlottesville, VA 22911. email: [email protected]. website: wardenbio.com. PluroGen Therapeutics, Inc. is a burn, wound, and skin care company … downhill driveway